10-K/AAMENDMENTELTXCIK 0001601485
Elicio Therapeutics, Inc.
Annual report (10-K/A) filed .
Comprehensive annual report filed by U.S. public companies, including audited financial statements, MD&A, and risk factors.
Filing facts
- Accession number
- 0001140361-24-022682
- Filer
- Elicio Therapeutics, Inc.
- Ticker
- ELTX
- CIK
- 0001601485
- Form type
- 10-K/A
- Form description
- Annual report
- Filed at
- April 29, 2024
- Period of report
- 2023-12-31
- Filing size
- 876.2 KB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1601485/000114036124022682/0001140361-24-022682-index.htm ↗Filer's full EDGAR submission history
EDGAR · Elicio Therapeutics, Inc. (0001601485) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001140361-24-022682.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.